drugset / Trial / NCT02709902

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

NCT02709902

Phase 1 Completed 460 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Bioequivalence with Clinical Endpoints.

Timeline

Start
2015-09
Primary completion
2016-02
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.3 % Topical
Subject Benzoyl Peroxide Other / unclassified 2.5 % Topical

Indications